Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy

被引：47
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Ctr Inflammatory Bowel Dis, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 05期
关键词：
INFLAMMATORY-BOWEL-DISEASE; INDUCTION THERAPY; INFLIXIMAB; MANAGEMENT;
D O I：
10.1038/ajg.2017.21
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：673 / 676
页数：4
相关论文
共 50 条
  • [31] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Manoj Kumar
    Selvasankar Murugesan
    Nazira Ibrahim
    Mamoun Elawad
    Souhaila Al Khodor
    Journal of Translational Medicine, 22
  • [32] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [33] Monitoring anti-TNF therapy in the nurse clinic
    Salih, AM
    Williams, E
    Cox, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 589 - +
  • [34] Utilizing Anti-TNF Levels and Drug Antibodies to De-escalate Therapy in Patients with IBD
    O'Brien, Corey
    Aguilar, Rodrigo
    Chang, Jennifer
    LeStrange, Aimee
    O'Hara, Melissa
    Mattar, Mark
    Charabaty, Aline
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S52 - S53
  • [35] Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
    Marquez-Megias, Silvia
    Nalda-Molina, Ricardo
    Sanz-Valero, Javier
    Mas-Serrano, Patricio
    Diaz-Gonzalez, Marcos
    Candela-Boix, Maria Remedios
    Ramon-Lopez, Amelia
    PHARMACEUTICS, 2022, 14 (05)
  • [36] Drug Induced Lupus on Anti-TNF Therapy
    Rashtak, Shahrooz
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S16 - S17
  • [37] Letter: dry blood spots for anti-TNF treatment monitoring in IBD
    Vande Casteele, N.
    Brecx, S.
    Declerck, P.
    Ferrante, M.
    Rutgeerts, P.
    Vermeire, S.
    Gils, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (10) : 1024 - 1025
  • [38] Real World Experience in Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Lack of Anti-Drug Antibodies to Vedolizumab and Ustekinumab Compared to Anti-TNF Agents in IBD
    Glassner, Kerri L.
    Oglat, Ayah
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S342 - S343
  • [39] Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
    Cheli, Stefania
    Savino, Diego
    Penagini, Francesca
    Zuccotti, Gianvincenzo
    Zuin, Giovanna
    Clementi, Emilio
    Cattaneo, Dario
    PHARMACEUTICS, 2023, 15 (07)
  • [40] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    DIGESTIVE DISEASES, 2015, 33 : 70 - 77
12345